Myriad Genetics Inc (MYGN)-Financial and Strategic SWOT Analysis Review

Myriad Genetics Inc (MYGN)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH7218FSA
  • |
  • Pages: 59
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Myriad Genetics Inc (MYGN)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Myriad Genetics Inc (Myriad) is a specialty molecular diagnostic company, which discovers and commercializes molecular diagnostic tests, personalized medicine and services for major diseases. The company's product portfolio includes molecular diagnostic testing products that are designed to analyze genes, their expression levels and corresponding proteins to assess a person risk for developing disease later in life, accurately diagnose disease and determine a patient's likelihood of responding to a particular drug. It also provides an array of pharmaceutical and clinical services. Myriad markets its products through its own sales force in Europe and Canada and through distributor agreements in Latin American, Middle Eastern, Asian and African countries. The company has operations in the US, Spain, France, Switzerland, the UK, Canada, the Netherlands and Italy. Myriad is headquartered in Salt Lake City, Utah, the US.

Myriad Genetics Inc Key Recent Developments

May 18,2017: Myriad Genetics to Present Seven Studies at the 2017 American Society of Clinical Oncology Annual Meeting

May 02,2017: Myriad Genetics Reports Fiscal Third-Quarter 2017 Financial Results

Apr 17,2017: Study Finds Wide Gap in Quality of BRCA1/2 Variant Classification Between Myriad Genetics and A Common Public Database

Feb 07,2017: Myriad Genetics Reports Fiscal Second-Quarter 2017 Financial Results

Nov 01,2016: Myriad Genetics Reports Fiscal First-Quarter 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Myriad Genetics Inc-Key Facts 6

Myriad Genetics Inc-Key Employees 7

Myriad Genetics Inc-Key Employee Biographies 8

Myriad Genetics Inc-Major Products and Services 9

Myriad Genetics Inc-History 11

Myriad Genetics Inc-Company Statement 17

Myriad Genetics Inc-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Section 2-Company Analysis 20

Myriad Genetics Inc-Business Description 20

Myriad Genetics Inc-Corporate Strategy 21

Myriad Genetics Inc-SWOT Analysis 22

SWOT Analysis-Overview 22

Myriad Genetics Inc-Strengths 22

Myriad Genetics Inc-Weaknesses 23

Myriad Genetics Inc-Opportunities 24

Myriad Genetics Inc-Threats 25

Myriad Genetics Inc-Key Competitors 26

Section 3-Company Financial Ratios 27

Financial Ratios-Capital Market Ratios 27

Financial Ratios-Annual Ratios 28

Performance Chart 31

Financial Performance 31

Financial Ratios-Interim Ratios 32

Financial Ratios-Ratio Charts 33

Section 4-Company's Lifesciences Financial Deals and Alliances 34

Myriad Genetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 34

Myriad Genetics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 35

Myriad Genetics Inc, Recent Deals Summary 36

Section 5-Company's Recent Developments 37

May 18, 2017: Myriad Genetics to Present Seven Studies at the 2017 American Society of Clinical Oncology Annual Meeting 37

May 02, 2017: Myriad Genetics Reports Fiscal Third-Quarter 2017 Financial Results 40

Apr 17, 2017: Study Finds Wide Gap in Quality of BRCA1/2 Variant Classification Between Myriad Genetics and A Common Public Database 43

Feb 07, 2017: Myriad Genetics Reports Fiscal Second-Quarter 2017 Financial Results 45

Nov 01, 2016: Myriad Genetics Reports Fiscal First-Quarter 2017 Financial Results 47

Oct 21, 2016: Myriad Genetics Forms Relationship with ION Solutions to Deliver Quality Hereditary Cancer Tests and Services to the Nation's Largest Network of Community Oncologists 49

Oct 17, 2016: Myriad Will Present New Data on Its Variant Classification Program at the ASHG Annual Meeting 50

Oct 04, 2016: The US Oncology Network Selects Myriad Genetics as Preferred Provider for Hereditary Cancer Testing 51

Sep 29, 2016: Myriad Appoints Chip Parkinson as EVP for Reimbursement Strategy 52

Aug 09, 2016: Myriad Genetics Reports Fiscal Fourth-Quarter 2016 Financial Results 53

Section 6-Appendix 55

Methodology 55

Ratio Definitions 55

About GlobalData 59

Contact Us 59

Disclaimer 59

List of Figures

Myriad Genetics Inc, Performance Chart (2012-2016) 31

Myriad Genetics Inc, Ratio Charts 33

Myriad Genetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 34

Myriad Genetics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 35

List of Tables

Myriad Genetics Inc, Key Facts 6

Myriad Genetics Inc, Key Employees 7

Myriad Genetics Inc, Key Employee Biographies 8

Myriad Genetics Inc, Major Products and Services 9

Myriad Genetics Inc, History 11

Myriad Genetics Inc, Subsidiaries 18

Myriad Genetics Inc, Key Competitors 26

Myriad Genetics Inc, Ratios based on current share price 27

Myriad Genetics Inc, Annual Ratios 28

Myriad Genetics Inc, Annual Ratios (Cont...1) 29

Myriad Genetics Inc, Annual Ratios (Cont...2) 30

Myriad Genetics Inc, Interim Ratios 32

Myriad Genetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 34

Myriad Genetics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 35

Myriad Genetics Inc, Recent Deals Summary 36

Currency Codes 55

Capital Market Ratios 55

Equity Ratios 56

Profitability Ratios 56

Cost Ratios 57

Liquidity Ratios 57

Leverage Ratios 58

Efficiency Ratios 58

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Myriad Genetics Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8750
Site License
USD 250 INR 17500
Corporate User License
USD 375 INR 26250

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com